Literature DB >> 11777975

Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection.

Margaret R Gyetko1, Sudha Sud, Gwo-Hsiao Chen, Jennifer A Fuller, Stephen W Chensue, Galen B Toews.   

Abstract

Urokinase-type plasminogen activator (uPA)(-/-) mice cannot mount protective host defenses during infection with the opportunistic yeast Cryptococcus neoformans (52D). Because effective host defense against C. neoformans requires specific immune responses and the generation of type 1 (T1) cytokines, we determined how the absence of uPA impacts these processes. Wild-type (WT) and uPA(-/-) mice were inoculated with C. neoformans. Macrophage antifungal activity was assessed histologically, T lymphocyte responses in vivo and proliferation in vitro were quantified, and cytokine concentrations were determined by ELISA. uPA(-/-) macrophages have impaired antimicrobial activity. Regional lymph nodes of infected uPA(-/-) mice contained fewer cells than WT, suggesting impaired T cell proliferation in response to the pathogen in vivo. In vitro, uPA(-/-) T lymphocytes had impaired proliferative responses to C. neoformans rechallenge compared with WT. Infected WT mice generated T1 cytokines in the lung, characterized by high levels of IFN-gamma and IL-12. uPA(-/-) mice had decreased levels of IFN-gamma and IL-12, and increased IL-5, a type 2 cytokine. In the absence of uPA, the cytokine profile of regional lymph nodes shifted from a T1 pattern characterized by IFN-gamma and IL-2 to a weak, nonpolarized response. We conclude that in the absence of uPA, lymphocyte proliferative responses are diminished, and mice fail to generate protective T1 cytokines, resulting in impaired antimicrobial activity. This study provides novel evidence that uPA is a critical modulator of immune responses and of immune cell effector functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777975     DOI: 10.4049/jimmunol.168.2.801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  SerpinB2 mediated regulation of macrophage function during enteric infection.

Authors:  Terez Shea-Donohue; Aiping Zhao; Toni M Antalis
Journal:  Gut Microbes       Date:  2014-02-05

2.  Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.

Authors:  Shinsuke Yasuda; Nasa Morokawa; G William Wong; Andrea Rossi; Mallur S Madhusudhan; Andrej Sali; Yuko S Askew; Roberto Adachi; Gary A Silverman; Steven A Krilis; Richard L Stevens
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

3.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

4.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion.

Authors:  Michal A Olszewski; Mairi C Noverr; Gwo-Hsiao Chen; Galen B Toews; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

6.  Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency.

Authors:  Zaixing Chen; Runzhen Zhao; Meimi Zhao; Xinrong Liang; Deepa Bhattarai; Rohan Dhiman; Sreerama Shetty; Steven Idell; Hong-Long Ji
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-29       Impact factor: 5.464

7.  The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.

Authors:  Jun Sato; Jeffrey Schorey; Victoria A Ploplis; Erijka Haalboom; Liana Krahule; Francis J Castellino
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Induction of brain microvascular endothelial cell urokinase expression by Cryptococcus neoformans facilitates blood-brain barrier invasion.

Authors:  Jamal Stie; Deborah Fox
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

9.  Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells.

Authors:  Sherry Thornton; Harini Raghu; Carolina Cruz; Malinda D Frederick; Joseph S Palumbo; Eric S Mullins; Kasper Almholt; Pernille A Usher; Matthew J Flick
Journal:  Blood Adv       Date:  2017-03-21

10.  Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.

Authors:  Jessica Meznarich; Laura Malchodi; Deri Helterline; Stephen A Ramsey; Kate Bertko; Tabitha Plummer; Abigail Plawman; Elizabeth Gold; April Stempien-Otero
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.